Home Mf Research Kotak Nifty Bank Etf
Kotak Mutual Fund

Kotak Nifty Bank ETF

Fund House : Kotak Mutual Fund
Overview
Returns
Portfolio
SIP Calculator
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
NAV (as on 2025-06-03)
571.96 -0.54%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
0.16%
Expense Ratio (Direct)
-%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-05-27 ₹1,000.00 ₹1,004.42
0.44 %
Two Week 2025-05-19 ₹1,000.00 ₹1,003.16
0.32 %
1 Month 2025-05-05 ₹1,000.00 ₹1,013.91
1.39 %
Three Months 2025-03-05 ₹3,000.00 ₹3,242.88
8.10 %
Six Months 2024-12-05 ₹6,000.00 ₹6,526.59
8.78 %
One Year 2024-06-03 ₹12,000.00 ₹12,970.50
8.09 %
Three Year 2022-06-06 ₹36,000.00 ₹44,817.56
24.49 %
Five Year 2020-06-04 ₹60,000.00 ₹89,519.43
49.20 %
Ten Year 2015-06-08 ₹120,000.00 ₹244,877.82
104.06 %
Since Inception 2014-11-24 ₹129,000.00 ₹319,450.54
147.64 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceuticals Industries Ltd. Pharmaceuticals and Biotechnology Equity 15.18
Cipla Ltd. Pharmaceuticals and Biotechnology Equity 8.3
Zydus Lifesciences Limited Pharmaceuticals and Biotechnology Equity 6.49
Divi's Laboratories Ltd. Pharmaceuticals and Biotechnology Equity 5.15
Dr. Reddy's Laboratories Ltd. Pharmaceuticals and Biotechnology Equity 4.9
Torrent Pharmaceuticals Ltd. Pharmaceuticals and Biotechnology Equity 4.79
Aurobindo Pharma Ltd. Pharmaceuticals and Biotechnology Equity 4.04
Marksans Pharma Ltd Pharmaceuticals and Biotechnology Equity 3.89
INNOVA CAPTABS LTD Pharmaceuticals and Biotechnology Equity 3.27
Glenmark Pharmaceuticals Ltd Pharmaceuticals and Biotechnology Equity 3.2
Ajanta Pharma Ltd. Pharmaceuticals and Biotechnology Equity 3.08
Alkem Laboratories Ltd. Pharmaceuticals and Biotechnology Equity 2.93
JB Chemicals & Pharmaceuticals Ltd. Pharmaceuticals and Biotechnology Equity 2.84
Laurus Labs Ltd. Pharmaceuticals and Biotechnology Equity 2.2
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals and Biotechnology Equity 2.06
Alembic Pharmaceuticals Ltd. Pharmaceuticals and Biotechnology Equity 1.92
Jubilant Pharmova Limited Pharmaceuticals and Biotechnology Equity 1.91
Biocon Ltd. Pharmaceuticals and Biotechnology Equity 1.88
Emcure Pharmaceuticals Limited Pharmaceuticals and Biotechnology Equity 1.86
Ami Organics Ltd Pharmaceuticals and Biotechnology Equity 1.75
Max Healthcare Institute Ltd. Healthcare Services Equity 4.77
Apollo Hospitals Enterprises Ltd. Healthcare Services Equity 2.59
Metropolis Healthcare Ltd. Healthcare Services Equity 2.11
Fortis Healthcare India Ltd. Healthcare Services Equity 1.97
Krishna Institute Of Medical Sciences Ltd. Healthcare Services Equity 1.87
GPT Healthcare Limited Healthcare Services Equity 1.79
Narayana Hrudayalaya Ltd. Healthcare Services Equity 1.5
Triparty Repo Money Market Other 1.92
Net Current Assets/(Liabilities) Unknown Other -
ITC Ltd. Diversified FMCG Equity 9.21
Hindustan Unilever Ltd. Diversified FMCG Equity 7.47
Maruti Suzuki India Limited Automobiles Equity 7.45
Hero MotoCorp Ltd. Automobiles Equity 5.70
Dabur India Ltd. Personal Products Equity 4.83
Emami Ltd. Personal Products Equity 3.29
Colgate Palmolive (India) Ltd. Personal Products Equity 2.49
Godrej Consumer Products Ltd. Personal Products Equity 2.41
Zomato Ltd. Retailing Equity 5.98
V-Mart Retail Ltd. Retailing Equity 1.39
Shoppers Stop Ltd. Retailing Equity 0.82
Bharti Airtel Ltd. Telecom - Services Equity 7.79
Titan Company Ltd. Consumer Durables Equity 2.84
Pokarna Ltd. Consumer Durables Equity 2.63
PVR Inox Limited Entertainment Equity 3.03
Sun TV Network Ltd. Entertainment Equity 1.88
Radico Khaitan Ltd. Beverages Equity 3.22
United Spirits Ltd. Beverages Equity 1.52
Samvardhana Motherson International Limited Auto Components Equity 2.49
Fortis Healthcare India Ltd. Healthcare Services Equity 1.47
Krishna Institute of Medical Sciences Healthcare Services Equity 1.20
V.S.T Tillers Tractors Ltd. Agricultural, Commercial and Construction Vehicles Equity 1.30
Inter Globe Aviation Ltd. Transport Services Equity 1.13
Central Government SOV Government Dated Securities 92.11
Triparty Repo - - 3.20
Net Current Assets/(Liabilities) - - 4.69
HDFC Bank Ltd. Banks Equity 27.47
ICICI Bank Ltd. Banks Equity 23.96
State Bank Of India Banks Equity 10.49
Kotak Mahindra Bank Ltd. Banks Equity 10.28
Axis Bank Ltd. Banks Equity 9.29
IndusInd Bank Ltd. Banks Equity 5.43
Federal Bank Ltd. Banks Equity 2.75
Bank Of Baroda Banks Equity 2.72
Punjab National Bank Banks Equity 2.12
AU Small Finance Bank Ltd. Banks Equity 2.07
IDFC First Bank Limited Banks Equity 1.96
Bandhan Bank Ltd. Banks Equity 1.03
Triparty Repo - Debt 0.01
Net Current Assets/(Liabilities) - - 0.42
SIP Calculator
Risk Ratios
Standard Deviation
-
Beta
-
Sharpe Ratio
-
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Ms. Shibani Sircar Kurian (), Mr. Abhishek Bisen (), Mr. Dhananjay Tikariha (), Mr. Devender Singhal (Unknown), Mr. Abhishek Bisen (Unknown), Mr. Abhishek Bisen (), Mr. Devender Singhal (), Mr. Satish Dondapati (),
  • Expense ration regular : 0.16
  • Expense ration direct : -
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹0.01
  • Type : others
Exit load
Nil

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?